TY - BOOK ID - 40137474 TI - Patentability of Chemical Selection Inventions PY - 2024 SN - 3845232188 3832965246 PB - La Vergne : e-book, DB - UniCat KW - Drugs KW - Patent laws and legislation KW - Conflict of laws KW - Drug development. KW - Olanzapine. KW - Citalopram. KW - Patents KW - Celexa KW - Citalopram Hydrobromide KW - Cytalopram KW - Escitalopram KW - Escitalopram Oxalate KW - Lexapro KW - Lu-10-171 KW - Seropram KW - Lu10171 KW - OLZ (Drug) KW - Antipsychotic drugs KW - Dopamine KW - Pirenzepine KW - Serotonin KW - Development of drugs KW - New drug development KW - Pharmacology KW - Pharmacy KW - Choice of law KW - Intermunicipal law KW - International law, Private KW - International private law KW - Private international law KW - Law KW - Legal polycentricity KW - Law, Patent KW - Scientific property KW - Industrial laws and legislation KW - Industrial property KW - Trade regulation KW - Copyright KW - Antagonists KW - Development KW - Civil law KW - Law and legislation KW - Markenrecht KW - Urheberrecht / Gewerblicher Rechtsschutz und Medienrecht KW - Gewerblicher Rechtsschutz UR - https://www.unicat.be/uniCat?func=search&query=sysid:40137474 AB - The thesis is a response to the recent decisions of the German Federal Court of Justice on the patentability requirements of selection inventions, namely, the Olanzapine and Escitalopram decisions. ER -